Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000103623-24-000088
Filing Date
2024-12-04
Accepted
2024-12-04 10:37:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2704
  Complete submission text file 0000103623-24-000088.txt   4221
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Subject) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35280 | Film No.: 241525193
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ANTARES PHARMA, INC. 707 EAGLEVIEW BOULEVARD, SUITE 414 EXTON PA 19341
Business Address
Wotton Paul K (Reporting) CIK: 0001300997 (see all company filings)

Type: 144